These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7536917)

  • 1. Ribavirin for hepatitis C infection.
    James DG
    Postgrad Med J; 1995 Feb; 71(832):120. PubMed ID: 7536917
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C treatment.
    Bresters D
    Curr Stud Hematol Blood Transfus; 1994; (61):121-36. PubMed ID: 7525154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C: ribavirin and/or interferon?
    Heathcote J
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S71-5. PubMed ID: 8986103
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hepatitis C infection. Review underplayed important public health issues.
    Agarwal K; Jones DD
    BMJ; 1999 Aug; 319(7207):450-1. PubMed ID: 10445936
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C. New treatment helps some, but cure remains elusive.
    Henkel J
    FDA Consum; 1999; 33(2):23-9. PubMed ID: 10214120
    [No Abstract]   [Full Text] [Related]  

  • 9. Barrier to resistance: lessons from 2 direct-acting hepatitis C virus inhibitors, MK-5172 and Sofosbuvir.
    Tong X; Kwong AD
    Clin Infect Dis; 2014 Dec; 59(12):1675-7. PubMed ID: 25266288
    [No Abstract]   [Full Text] [Related]  

  • 10. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection.
    de Knegt RJ; van den Berg AP
    N Engl J Med; 2001 Nov; 345(19):1427; author reply 1427-8. PubMed ID: 11794188
    [No Abstract]   [Full Text] [Related]  

  • 12. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV/HCV co-infection has treatment implications.
    Murphy MJ
    HIV Clin; 2000; 12(2):1, 5. PubMed ID: 11810826
    [No Abstract]   [Full Text] [Related]  

  • 14. Infection fighters. Hepatitis C--is a cure possible?
    TreatmentUpdate; 2005; 17(1):8-9. PubMed ID: 17225319
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: somber views of natural history and optimistic views of interferon treatment?
    Poynard T; Opolon P
    Hepatology; 1998 May; 27(5):1443-4. PubMed ID: 9581705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
    Delwaide J
    Rev Med Liege; 1998 Aug; 53(8):467-9. PubMed ID: 9810206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C: How should we manage the patient?
    Main J; Thomas H
    J Viral Hepat; 2004 Sep; 11 Suppl 1():19-22. PubMed ID: 15357859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.